Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer (<scp>NMIBC</scp>) with emphasis on the use of bacillus <scp>C</scp>almette‐<scp>G</scp>uérin (<scp>BCG</scp>): results of an international individual patient data survey (<scp>IPDS</scp>)
Distribution of the number of citations over years.